Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Diagnostic Equipment

Catalyst and Catalyst+ Radiotherapy Systems Recalled for Positioning Errors

Agency Publication Date: January 14, 2026
Share:
Sign in to monitor this recall

Summary

C-RAD POSITIONING AB is recalling Catalyst and Catalyst+ patient positioning systems, specifically 189 units using the cSRS software module in combination with the cMotion module. The system may incorrectly indicate that a patient is properly aligned for stereotactic radiosurgery (SRS) even when their position is outside of the safe tolerance limits. Consumers should contact the manufacturer or their healthcare facility supervisor to address this software issue.

Risk

If a patient is incorrectly positioned during radiotherapy, the treatment may be delivered to the wrong area. This could lead to radiation damage to healthy tissue or an ineffective treatment of the target area.

What You Should Do

  1. The recalled products are C-RAD Catalyst and Catalyst+ patient positioning devices (models SP001-0026 and SP003-0002) that utilize the cSRS software module in combination with the cMotion module.
  2. Clinicians and facility staff should verify if their system configuration includes the affected software modules and if the equipment is used for stereotactic radiosurgery (SRS) setups.
  3. Stop using the recalled device for affected treatment setups. Contact the manufacturer or your distributor to arrange for a system correction or software update.
  4. For additional questions or to report a problem, call the FDA at 1-888-463-6332 or visit www.fda.gov/medical-devices/medical-device-recalls.

Your Remedy Options

๐Ÿ“‹Other Action
How to: Stop using the recalled device. Contact the manufacturer or your distributor to arrange return, replacement, or correction.

Affected Products

Product: Catalyst, Catalyst+ Patient Positioning Device
Variants: cSRS software module, cMotion software module
Model / REF:
SP001-0026
SP003-0002

The error is not related to any serial numbers or LOT numbers; it is limited to the software module cSRS in combination with cMotion module.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 97872
Status: Active
Manufacturer: C-RAD POSITIONING AB
Sold By: Hospitals; Radiotherapy centers; Direct distribution
Manufactured In: Sweden
Units Affected: 189
Distributed To: Alaska, Alabama, Arkansas, California, Connecticut, Florida, Missouri, North Carolina, New Mexico, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Virginia, Washington

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.